Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions – Fourth Meeting
In response to a Congressional request, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine is conducting a study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. This is the fourth meeting of the committee of